NL
ENG
Home
About hollandbio
Programs
Rock-solid innovation climate
Future-proof planet
Personalized health
News
Events
Sectorinfo
Dutch Life Science Database
Members
Members Platform
Member benefits
Event discounts
Hollandbio partners
Become a member
Contact
Login
Click to open the search input field
Click to open the search input field
Search
Menu
Menu
taalswitcher
NL
ENG
#news
Breakingbiotechnews!
The most relevant news from medical, agri-food and industrial biotech.
Hans Schikan start als special envoy vaccins
22 February 2021
Invest-NL investeert via het ‘Innovation Industries Fonds II’ in Deep Tech
17 February 2021
Life sciences zijn in trek binnen de zorgovernamemarkt
16 February 2021
Investeren in R&D en innovatie helpt ons de crisis uit
16 February 2021
DEBx Medical publishes first clinical data on novel desiccant gel for chemical debridement of infected, chronic wounds in peer-reviewed journal, Wounds
16 February 2021
Leestip: kosteneffectiviteit voor eenmalige (CAR-T) behandelingen
16 February 2021
Uitgebreide DNA-test voor iedere kankerpatiënt ideale wegbereider voor implementatie van technologische innovaties
16 February 2021
Terugblik webinar over versnelde vergunningsprocedure gentherapie
16 February 2021
InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors
16 February 2021
European Commission grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia
16 February 2021
Launch of novel gene therapy company, VectorY, to develop innovative vectorized antibodies
16 February 2021
Vaccins produceren is geen pannenkoeken bakken
9 February 2021
Nederland verder op de kaart na komst EMA
9 February 2021
InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M
9 February 2021
De coronavrije samenleving heeft een deltaplan infectieziekten nodig
9 February 2021
Vaccinproductie draagt bij aan economisch herstel Nederlandse industrie
9 February 2021
Catapult Therapeutics receives FDA Clearance of Investigational New Drug (IND) Application for CAP-100, an innovative first-in-class humanized anti-CCR7 antibody
9 February 2021
Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center
8 February 2021
Page 58 of 126
Older posts
Newer posts
Pagina 58 van 126
«
‹
56
57
58
59
60
›
»
Scroll to top
Scroll to top
Scroll to top